APA 6th Edition TOMIĆ, S., MILČIĆ, N., SOKOLIĆ, M., FILIPOVIĆ SUČIĆ, A. i ILIĆ MARTINAC, A. (2010). IMA LI U HRVATSKOJ KRIVOTVORENIH LIJEKOVA?. Liječnički vjesnik, 132 (3-4), 81-86. Preuzeto s https://hrcak.srce.hr/63564
MLA 8th Edition TOMIĆ, SINIŠA, et al. "IMA LI U HRVATSKOJ KRIVOTVORENIH LIJEKOVA?." Liječnički vjesnik, vol. 132, br. 3-4, 2010, str. 81-86. https://hrcak.srce.hr/63564. Citirano 27.02.2020.
Chicago 17th Edition TOMIĆ, SINIŠA, NEVEN MILČIĆ, MILENKO SOKOLIĆ, ANITA FILIPOVIĆ SUČIĆ i ADRIJANA ILIĆ MARTINAC. "IMA LI U HRVATSKOJ KRIVOTVORENIH LIJEKOVA?." Liječnički vjesnik 132, br. 3-4 (2010): 81-86. https://hrcak.srce.hr/63564
Harvard TOMIĆ, S., et al. (2010). 'IMA LI U HRVATSKOJ KRIVOTVORENIH LIJEKOVA?', Liječnički vjesnik, 132(3-4), str. 81-86. Preuzeto s: https://hrcak.srce.hr/63564 (Datum pristupa: 27.02.2020.)
Vancouver TOMIĆ S, MILČIĆ N, SOKOLIĆ M, FILIPOVIĆ SUČIĆ A, ILIĆ MARTINAC A. IMA LI U HRVATSKOJ KRIVOTVORENIH LIJEKOVA?. Liječnički vjesnik [Internet]. 2010 [pristupljeno 27.02.2020.];132(3-4):81-86. Dostupno na: https://hrcak.srce.hr/63564
IEEE S. TOMIĆ, N. MILČIĆ, M. SOKOLIĆ, A. FILIPOVIĆ SUČIĆ i A. ILIĆ MARTINAC, "IMA LI U HRVATSKOJ KRIVOTVORENIH LIJEKOVA?", Liječnički vjesnik, vol.132, br. 3-4, str. 81-86, 2010. [Online]. Dostupno na: https://hrcak.srce.hr/63564. [Citirano: 27.02.2020.]
Sažetak Counterfeit medicines are a growing problem in the world, for their use may endanger patient’s health and therefore they pose an enormous public health risk. The manufacture of counterfeit medicines usually involves organised crime groups which place the counterfeit medicines on the market for reasons of profit. Detection and prevention of trade in counterfeit medicines requires close cooperation between medicine regulatory authorities, police, customs, judiciary and pharmaceutical industry. To this day, there have been no recorded cases of counterfeit medicines in the legal supply chain in Croatia. However, medicines without marketing authorisation in Croatia, originating from different countries, could be found on the illegal market. Most frequently, this includes medicines for the treatment of erectile dysfunction such as: sildenafil, tadalafil, vardenafil. In this study, 26 medicines for the treatment of erectile dysfunction, seized in illegal supply chain, were tested. High performance liquid chromatography (HPLC) was used for identification and quantification of active substances in the tested samples. It was determined that 13 out of 26 samples did not comply with declared composition of medicine and quality specification. Furthermore, two samples did not contain declared active substance vardenafil and that may indicate that these medicines are counterfeit.